Ozempic is an injectable medication containing semaglutide, which belongs to a class of drugs called GLP-1 receptor agonists. It’s mainly used to manage blood sugar levels in adults with type 2 diabetes. Semaglutide mimics the action of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate the release of insulin when you eat. This helps to control your blood sugar levels, and is shown to be effective at supporting weight loss alongside lifestyle changes.

Individual results with Ozempic (semaglutide) can vary from person to person. In clinical trials, for people with type 2 diabetes, people using Ozempic achieved weight loss ranging from around 7% to more than 12% of their initial body weight, on average.

Your weight loss can be influenced by various factors, including individual responses to the medication, consistency with treatment, lifestyle changes, metabolic differences and overall health. Some people might experience more significant weight loss, while others may see more moderate changes.

The science behind Ozempic

The active ingredient in Ozempic, semaglutide, is a GLP-1 receptor agonist that mimics a naturally occurring hormone in the body.

When injected, it activates GLP-1 receptors in the pancreas, brain, and stomach. This activation aids in regulating blood sugar levels by increasing insulin secretion in response to high blood sugar, while alsoreducing appetite and promoting a feeling of fullness.

Additionally, Ozempic slows down gastric emptying, contributing to improved blood sugar control and potentially aiding weight loss in individuals with type 2 diabetes.